Literature DB >> 6621103

Continuous ambulatory peritoneal dialysis. Three years' experience at the Mayo Clinic.

S B Kurtz, V H Wong, C F Anderson, J P Vogel, J T McCarthy, J C Mitchell, R Kumar, W J Johnson.   

Abstract

From January 1979 through January 1982, 69 patients with end-stage renal failure of various causes were treated by continuous ambulatory peritoneal dialysis. The dialysis was adequate and stable in all except four patients; two of these four became irreversibly uremic, and the other two had inadequate ultrafiltration. Hemoglobin levels increased initially and remained stable in all but two patients. In our experience, metabolic problems included control of secondary hyperparathyroidism, adequate protein nutrition, progressive neuropathy, abnormal lipoprotein profiles, and excessive weight gain. Technical problems included recurrent peritonitis, maintenance of adequate peritoneal access, and development of abdominal hernias. In general, all but two patients remained enthusiastic about this type of therapy despite inherent problems. The long-term potential of continuous ambulatory peritoneal dialysis remains uncertain at this point, but for most patients, adequate short-term treatment by this method is a reasonable alternative to hemodialysis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6621103

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  5 in total

1.  Increased peritoneal permeability in patients with peritonitis undergoing continuous ambulatory peritoneal dialysis.

Authors:  M E McIntosh; W G Smith; B J Junor; G Forrest; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid.

Authors:  I Shalit; D F Welch; V H San Joaquin; M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

3.  Older Age, Higher Body Mass Index and Inflammation Increase the Risk for New-Onset Diabetes and Impaired Glucose Tolerance in Patients on Peritoneal Dialysis.

Authors:  Jie Dong; Zhi-Kai Yang; Yuan Chen
Journal:  Perit Dial Int       Date:  2016-02-04       Impact factor: 1.756

4.  Metabolic syndrome in peritoneal dialysis patients.

Authors:  Philip Kam-Tao Li; Bonnie Ching-Ha Kwan; Cheuk Chun Szeto; Gary Tin-Choi Ko
Journal:  NDT Plus       Date:  2008-06-27

Review 5.  New-Onset Diabetes Mellitus in Peritoneal Dialysis and Hemodialysis Patients: Frequency, Risk Factors, and Prognosis-A Review.

Authors:  Rajashri Yarragudi; Alois Gessl; Andreas Vychytil
Journal:  Ther Apher Dial       Date:  2019-04-23       Impact factor: 1.762

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.